Published in ACS Nano on September 01, 2016
Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics. Drug Discov Today (2014) 0.91
Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer. Nat Commun (2015) 0.91
Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2. Nat Commun (2015) 0.83
Outwitting EF-Tu and the ribosome: translation with d-amino acids. Nucleic Acids Res (2015) 0.78
Expanding biohybrid-mediated asymmetric catalysis into the realm of RNA. Chem Commun (Camb) (2016) 0.75